These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. Confavreux C; Suissa S; Saddier P; Bourdès V; Vukusic S; N Engl J Med; 2001 Feb; 344(5):319-26. PubMed ID: 11172162 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccination and the risk of multiple sclerosis. Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccine and risk of multiple sclerosis. Destefano F; Weintraub ES; Chen RT Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):705-7, author reply 707-8. PubMed ID: 17549685 [No Abstract] [Full Text] [Related]
5. Hepatitis B vaccine and risk of multiple sclerosis. DeStefano F; Verstraeten T; Chen RT Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584 [TBL] [Abstract][Full Text] [Related]
6. [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]. Löbermann M; Handorn B; Winkelmann A; Reisinger EC; Hartung HP; Zettl UK Nervenarzt; 2018 Oct; 89(10):1172-1178. PubMed ID: 29404651 [TBL] [Abstract][Full Text] [Related]
7. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates. Gunn TR; Bosley A; Woodfield DG N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527 [TBL] [Abstract][Full Text] [Related]
8. [Vaccination against hepatitis B and the risk of multiple sclerosis]. Magdzik W; Zieliński A Przegl Epidemiol; 2005; 59(1):11-9. PubMed ID: 16013405 [TBL] [Abstract][Full Text] [Related]
9. Erythema nodosum after Recombivax HB hepatitis B vaccine. Goolsby PL N Engl J Med; 1989 Oct; 321(17):1198-9. PubMed ID: 2529439 [No Abstract] [Full Text] [Related]
10. Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis. Wu T; Zhu FC; Huang SJ; Zhang XF; Wang ZZ; Zhang J; Xia NS Hepatology; 2012 Jun; 55(6):2038. PubMed ID: 22161542 [No Abstract] [Full Text] [Related]
11. Adjustment of Europe's drug regulation to public- health needs. Wolff F Lancet; 2001 Nov; 358(9294):1733-4. PubMed ID: 11728586 [No Abstract] [Full Text] [Related]
12. Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Terney D; Beniczky S; Barsi P; Kondákor I; Perényi J; Faludi B; Szapper M; Vécsei L Chin Med J (Engl); 2006 Jan; 119(1):77-9. PubMed ID: 16454987 [No Abstract] [Full Text] [Related]
13. When vaccine injury claims go to court. Stewart AM N Engl J Med; 2009 Jun; 360(24):2498-500. PubMed ID: 19516030 [No Abstract] [Full Text] [Related]
14. Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? A decision analysis. Sacks HS; Rose DN; Chalmers TC JAMA; 1984 Dec; 252(24):3375-7. PubMed ID: 6239044 [TBL] [Abstract][Full Text] [Related]
15. [Hepatitis B vaccination and multiple sclerosis: from medical uncertainty to compensation for victims]. Schütze T; Bouvet R; Le Gueut M Rev Neurol (Paris); 2014; 170(8-9):520-6. PubMed ID: 24854962 [TBL] [Abstract][Full Text] [Related]
16. Europe's drug agency will publish clinical trial data for new products from 2014. Torjesen I BMJ; 2012 Nov; 345():e8061. PubMed ID: 23183072 [No Abstract] [Full Text] [Related]
17. Preventing transmission of hepatitis B. McLellan TS; Hutnik SS J Mich Dent Assoc; 1992 Mar; 74(3):20-2, 61. PubMed ID: 1625328 [No Abstract] [Full Text] [Related]